Trivalent inactivated influenza vaccine response and immunogenicity assessment after one week and three months in repeatedly vaccinated adults

Trivalent inactivated influenza vaccine response and immunogenicity assessment after one week and three months in repeatedly vaccinated adults

Background The influenza vaccine administrated every year is a recommended infection control procedure for individuals above the age of six months. However, the effectiveness of repeated annual vaccination is still an active research topic. Therefore, we investigated the vaccine immunogenicity in tw...

Full description

Bibliographic Details
Main Authors:	Ahmed Tawfik, Takahisa Kawaguchi, Meiko Takahashi, Kazuya Setoh, Izumi Yamaguchi, Yasuharu Tabara, Kristel Van Steen, Anavaj Sakuntabhai, Fumihiko Matsuda
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2023-12-01
Series:	Expert Review of Vaccines
Subjects:	influenza vaccine vaccine response yearly flu vaccination influenza vaccine immunogenicity influenza vaccine response
Online Access:	http://dx.doi.org/10.1080/14760584.2023.2262563

Similar Items

Transcriptomic Analysis Reveals Sixteen Potential Genes Associated with the Successful Differentiation of Antibody-Secreting Cells through the Utilization of Unfolded Protein Response Mechanisms in Robust Responders to the Influenza Vaccine
by: Ahmed Tawfik, et al.
Published: (2024-01-01)

Factors affecting the immunogenicity of influenza vaccines in human
by: Qiuyi Xu, et al.
Published: (2023-04-01)

Public knowledge on influenza and influenza vaccines
by: Adrianna Gorecka, et al.
Published: (2021-08-01)

Immunogenicity Measures of Influenza Vaccines: A Study of 1164 Registered Clinical Trials
by: Alexander Domnich, et al.
Published: (2020-06-01)

Factors influencing the immunogenicity of influenza vaccines
by: Simin Wen, et al.
Published: (2021-08-01)

Immunogenicity and safety of a trivalent inactivated influenza vaccine produced in Shenzhen, China versus a comparator influenza vaccine: a phase IV randomized study
by: Yuemei Hu, et al.
Published: (2019-05-01)

A 12-month follow-up of an influenza vaccination campaign based on voluntary adherence: report on upper-respiratory symptoms among volunteers and non-volunteers
by: Páris Ali Ramadan, et al.

Immunogenicity of adjuvanted versus high-dose inactivated influenza vaccines in older adults: a randomized clinical trial
by: Kenneth E. Schmader, et al.
Published: (2023-07-01)

Immunogenicity and safety of seasonal influenza vaccines in children under 3 years of age
by: Tia Aoun, et al.
Published: (2023-12-01)

Safety and immunogenicity of a quadrivalent influenza vaccine in adults 65 y of age and older
by: David P. Greenberg, et al.
Published: (2017-09-01)

Evaluating the Relative Vaccine Effectiveness of Adjuvanted Trivalent Influenza Vaccine Compared to High-Dose Trivalent and Other Egg-Based Influenza Vaccines among Older Adults in the US during the 2017–2018 Influenza Season
by: Stephen I. Pelton, et al.
Published: (2020-08-01)

Relative Vaccine Effectiveness of Adjuvanted Trivalent Influenza Vaccine over Three Consecutive Influenza Seasons in the United States
by: Constantina Boikos, et al.
Published: (2022-09-01)

Immunogenicity and safety of a trivalent inactivated influenza vaccine
by: Eddy Fadlyana, et al.
Published: (2011-02-01)

Immunogenicity and safety of inactivated quadrivalent influenza vaccine compared with the trivalent vaccine for influenza infection: an overview of systematic reviews
by: Rodrigo Luiz Carregaro, et al.
Published: (2023-08-01)

Rollout of the 2022/2023 Seasonal Influenza Vaccination and Correlates of the Use of Enhanced Vaccines among Italian Adults
by: Luca Pestarino, et al.
Published: (2023-11-01)

A Randomized Controlled Study to Evaluate the Safety and Reactogenicity of a Novel rVLP-Based Plant Virus Nanoparticle Adjuvant Combined with Seasonal Trivalent Influenza Vaccine Following Single Immunization in Healthy Adults 18–50 Years of Age
by: Joanne Langley, et al.
Published: (2020-07-01)

Nurses’ Influenza Vaccination and Hesitancy: A Systematic Review of Qualitative Literature
by: Natacha Pinatel, et al.
Published: (2022-06-01)

A trivalent, inactivated influenza vaccine (Vaxigrip®): summary of almost 50 years of experience and more than 1.8 billion doses distributed in over 120 countries
by: Margaret Haugh, et al.
Published: (2017-06-01)

Safety of anti-influenza vaccination during pregnancy
by: Marta Kozłowska, et al.
Published: (2020-09-01)

Rapid safety assessment of a seasonal intradermal trivalent influenza vaccine
by: Marc Demeulemeester, et al.
Published: (2017-04-01)

Gulllain-Barre Syndrome After Trivalent Influenza Vaccination in Adults
by: Kuo-Hsuan Chang, et al.
Published: (2019-07-01)

Evaluation of knowledge and barriers of influenza vaccine uptake among university students in Saudi Arabia; a cross-sectional analysis
by: Tauqeer Hussain Mallhi, et al.
Published: (2022-09-01)

Impact of Influenza Vaccination on Mortality in the Oldest Old: A Propensity Score-Matched Cohort Study
by: Pauline Walzer, et al.
Published: (2020-07-01)

Detection of Twitter Users\' Attitudes about Flu Vaccine based on the Content and Sentiment Analysis of the Sent Tweets
by: Zahra Ghanbari, et al.
Published: (2019-03-01)

Immunogenicity and Clinical Efficacy of Influenza Vaccination In Pregnancy
by: Alexander W Kay, et al.
Published: (2015-06-01)

Analysis of Viral and Host Factors on Immunogenicity of 2018, 2019, and 2020 Southern Hemisphere Seasonal Trivalent Inactivated Influenza Vaccine in Adults in Brazil
by: Artur Capão, et al.
Published: (2022-07-01)

Immunogenicity and safety of a multi-dose quadrivalent inactivated influenza vaccine in individuals aged 6 months to 17 years: a randomized phase III trial
by: Joyce Ojeda, et al.
Published: (2020-06-01)

Immune response to influenza vaccination in children with cancer
by: Dimitrios Doganis, et al.
Published: (2018-09-01)

A Comparison of the Level of Acceptance and Hesitancy towards the Influenza Vaccine and the Forthcoming COVID-19 Vaccine in the Medical Community
by: Magdalena Grochowska, et al.
Published: (2021-05-01)

Enhancing Immunogenicity of Influenza Vaccine in the Elderly through Intradermal Vaccination: A Literature Analysis
by: Huy Quang Quach, et al.
Published: (2022-11-01)

A New Master Donor Virus for the Development of Live-Attenuated Influenza B Virus Vaccines
by: Chantelle L. White, et al.
Published: (2021-06-01)

The immune response to 6-monthly versus annual standard dose inactivated trivalent influenza vaccination in older people: study protocol for a randomised clinical trial
by: Young, Barnaby, et al.
Published: (2017)

Influenza and Universal Vaccine Research in China
by: Jiali Li, et al.
Published: (2022-12-01)

Next Generation Influenza Vaccines: Looking into the Crystal Ball
by: Carlos Alberto Guzmán
Published: (2020-08-01)

Trivalent mRNA vaccine-candidate against seasonal flu with cross-specific humoral immune response
by: Elena P. Mazunina, et al.
Published: (2024-04-01)

Quadrivalent inactivated influenza vaccine (VaxigripTetra™)
by: Viviane Gresset-Bourgeois, et al.
Published: (2018-01-01)

Development of the quadrivalent live attenuated influenza vaccine including two influenza B lineages – Victoria and Yamagata
by: Yu. A. Desheva, et al.
Published: (2016-02-01)

Investigation of the Reasons for Influenza Vaccine Refusal in Healthcare Workers in the COVID-19 Pandemic
by: Derya KORKMAZ, et al.
Published: (2023-06-01)

Efficacy, safety and immunogenicity of a trivalent inactivated split influenza vaccine in patients with rheumatic diseases
by: D. V. Bukhanova, et al.
Published: (2018-07-01)

Coverage of influenza vaccination of patients with diabetes and determination of barriers for implementation of vaccination
by: I. O. Vlasenko, et al.
Published: (2022-12-01)